5UV-22638-49054
3 vaccinations
10 coded responses
37 check-ins
10 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 628 / IL
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-31
-
2021-01-07
Survey response — day 21, dose 1MedDRA: Headache, Self-medication — Feeling: FairFree text: Headache not relieved by over the counter medicationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body achesAdult check-in
- 2021-01-10
- 2021-01-11
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Asthma — Feeling: GoodFree text: Asthma attackMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-22
-
2021-01-29
Survey response — day 21, dose 2MedDRA: Unevaluable event — Feeling: FairFree text: Sinus issues which appear to be due to allergies. They respond to increase in allergy medication.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-12
-
2021-02-19
Survey response — day 42, dose 2MedDRA: Sinusitis — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Report sent to call center — day 42, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-09
Survey response — 3 months, dose 2MedDRA: Vertigo — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe Vertigo. On ongoing steroidsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-11
Survey response — 6 months, dose 2MedDRA: Female reproductive tract disorder, Sinusitis — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continue sinus infections and female issues that complicate what antibiotics I can takeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-11
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-15
-
2021-07-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-07-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-07-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Cardiac flutter — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Mild heart fluttering last nightMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Joint pains, Muscle or body achesAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-10-03
- 2021-10-05
- 2021-10-12
- 2021-10-19
-
2021-10-26
Survey response — day 28, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Flare up in preexisting gi symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-28
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-02
- 2021-11-09
- 2021-12-28
-
2022-03-29
Survey response — 6 months, dose 3MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Slight increase in Multiple Sceleosis symptoms but nothing that indicates new lesionsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-30
Call successfulDoes not wish to fill out VAERS report
-
2022-09-29
Survey response — 12 months, dose 3MedDRA: Inflammation, Mobility decreased, Office visit, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Arthritis in several joints. Doctors recommended a knee replacement. Mobility has declined. Lots of inflammation, blood test ordered.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-30
-
2022-09-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
6 call center cases
6 successful
Free text
Release 1 — day 21, dose 1
Symptoms: Headache not relieved by over the counter medication
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Asthma attack
Release 3 — day 21, dose 2
Symptoms: Sinus issues which appear to be due to allergies. They respond to increase in allergy medication.
Release 4 — day 42, dose 2
Symptoms: Sinus infection
Release 7 — 3 months, dose 2
Symptoms: Severe Vertigo. On ongoing steroids
Release 9 — 6 months, dose 2
Symptoms: Continue sinus infections and female issues that complicate what antibiotics I can take
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Mild heart fluttering last night
Release 10 — day 28, dose 3
Symptoms: Flare up in preexisting gi symptoms
Release 11 — 6 months, dose 3
Symptoms: Slight increase in Multiple Sceleosis symptoms but nothing that indicates new lesions
Release 12 — 12 months, dose 3
Symptoms: Arthritis in several joints. Doctors recommended a knee replacement. Mobility has declined. Lots of inflammation, blood test ordered.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Female reproductive tract disorder | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Multiple sclerosis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Cardiac flutter | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release